MedTrace Logo

Evaluation of mediVR-KAGURA Guided Therapy

NCT04562662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-08-16

No results posted yet for this study

Summary

The objective is to evaluate mediVR-KAGURA guided therapy for the treatments of physical and cognitive dysfunctions regardless of baseline disease in a prospective interventional design.

Conditions

  • Physical Disability
  • Cognitive Dysfunction

Interventions

DEVICE

mediVR KAGURA

Approximately 20 min mediVR KAGURA-guided rehabilitation

Sponsors & Collaborators

  • Japan Society of Clinical Research

    lead OTHER

Principal Investigators

  • Masahiko Hara, MD, PhD · Cloud Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04562662 on ClinicalTrials.gov